mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

Creative Commons License

Yekeduz E., Ayasun R., Koksoy E. B., Utkan G., ÜRÜN Y., AKBULUT H.

FUTURE VIROLOGY, vol.16, pp.583-585, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 16
  • Publication Date: 2021
  • Doi Number: 10.2217/fvl-2021-0166
  • Journal Name: FUTURE VIROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE
  • Page Numbers: pp.583-585
  • Keywords: cancer, COVID-19, immunotherapy, mRNA, SARS-CoV-2, vaccine, INFLUENZA VACCINATION, SAFETY, IMMUNOGENICITY
  • Open Archive Collection: AVESIS Open Access Collection
  • Hacettepe University Affiliated: Yes